APA (7th ed.) Citation

Sho, T., Suda, G., Nagasaka, A., Yamamoto, Y., Furuya, K., Kumagai, K., . . . Sakamoto, N. (2018). Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction. Hepatology research, 48(7), 529-538. https://doi.org/10.1111/hepr.13056

Chicago Style (17th ed.) Citation

Sho, Takuya, et al. "Safety and Efficacy of Sofosbuvir and Ribavirin for Genotype 2 Hepatitis C Japanese Patients with Renal Dysfunction." Hepatology Research 48, no. 7 (2018): 529-538. https://doi.org/10.1111/hepr.13056.

MLA (9th ed.) Citation

Sho, Takuya, et al. "Safety and Efficacy of Sofosbuvir and Ribavirin for Genotype 2 Hepatitis C Japanese Patients with Renal Dysfunction." Hepatology Research, vol. 48, no. 7, 2018, pp. 529-538, https://doi.org/10.1111/hepr.13056.